Implementation of Alcohol Screening and Brief Intervention in a Health System: Sustainability, Fidelity and Patient Outcomes

在卫生系统中实施酒精筛查和短暂干预:可持续性、忠诚度和患者结果

基本信息

项目摘要

Project Summary/Abstract The COVID-19 pandemic has led to a dramatic shift to virtual treatment for patients with alcohol problems. This shift raises questions about potential disparities in access to virtual treatment, given the existing ‘digital divide,’ where older patients, patients of color, and patients of lower socio-economic status may have less access to broadband, computers, and other digital devices. Patients may also face barriers such as confidentiality concerns, lack of private space for participating in virtual sessions, and dissatisfaction with the virtual therapeutic experience. At the same time, features of virtual treatment, such as convenience and elimination of transportation and its costs, may increase access and use, particularly for underrepresented patient populations. The proposed study examines disparities in virtual alcohol treatment among patients with alcohol problems, defined as both excessive alcohol use and alcohol use disorder (AUD) in a large, diverse, health care delivery system that was able to quickly pivot to virtual alcohol treatment delivery during the pandemic. Using rich electronic health record and claims data, we examine changes in alcohol problem identification, and in several treatment measures (brief intervention, pharmacotherapy, and initiation, engagement, and retention in specialty addiction treatment) comparing visit types (virtual/non-virtual, telephone, video) from a pre- COVID-19 (3/2019-12/2019) to post-COVID-19 onset (3/2020-12/2020) time period. With a large sample of 205,293 patients with alcohol problems, we will specifically explore disparities by race/ethnicity, gender, age, and socioeconomic status, and examine different severity levels of alcohol problems. We explore differential insurance loss during this turbulent time, as well as health services utilization (e.g. emergency department, primary care, psychiatry, email secure messages) by the study population. Our rigorous analytic plan incorporates interrupted time series (ITS), and generalized estimating equation (GEE) models to address study aims. Early evidence suggests alcohol problems have increased during the COVID-19 pandemic, and virtual treatment will likely continue post-pandemic as an important treatment modality. Findings have important implications for patient care, particularly for improving quality of care for vulnerable populations. Further, the study cohort will be a valuable resource for future research on virtual alcohol treatment, and its long-term impact on patient outcomes.
项目概要/摘要 COVID-19 大流行导致酗酒患者转向虚拟治疗 问题。这种转变引发了有关获得虚拟治疗的潜在差异的问题, 鉴于现有的“数字鸿沟”,老年患者、有色人种患者和低收入患者 社会经济地位可能较少获得宽带、计算机和其他数字产品 设备。患者还可能面临保密问题、缺乏私人空间等障碍 参与虚拟会议以及对虚拟治疗体验的不满。在 同时,虚拟治疗具有方便、省去等特点。 运输及其成本,可能会增加获取和使用,特别是对于代表性不足的人 患者人群。拟议的研究调查了虚拟酒精治疗中的差异 有酒精问题的患者,定义为过度饮酒和酒精使用障碍 (澳元)在一个大型、多样化的医疗保健提供系统中,该系统能够快速转向虚拟 大流行期间提供酒精治疗。使用丰富的电子健康记录和索赔 数据,我们检查酒精问题识别和几种治疗措施的变化 (简短的干预、药物治疗以及专业的启动、参与和保留 成瘾治疗)比较预治疗的访问类型(虚拟/非虚拟、电话、视频) COVID-19(3/2019-12/2019)到 COVID-19 发病后(3/2020-12/2020)时间段。与一个 205,293名有酒精问题的患者的大样本,我们将专门探讨差异 按种族/民族、性别、年龄和社会经济地位,并检查不同的严重程度 酒精问题。我们探讨了这个动荡时期的差异保险损失,以及 卫生服务利用(例如急诊室、初级保健、精神病学、电子邮件安全 消息)由研究人群。我们严格的分析计划包含了中断时间 系列(ITS)和广义估计方程(GEE)模型来解决研究目标。早期的 有证据表明,在 COVID-19 大流行期间,酗酒问题有所增加,并且 虚拟治疗可能会在大流行后继续作为一种重要的治疗方式。发现 对患者护理具有重要意义,特别是对于提高护理质量 弱势群体。此外,研究队列将成为未来研究的宝贵资源 虚拟酒精治疗及其对患者结果的长期影响。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Stacy Ann Sterling其他文献

Stacy Ann Sterling的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Stacy Ann Sterling', 18)}}的其他基金

Virtual SBIRT for Pediatric Primary Care: Increasing Access to Screening, Brief Intervention and Referral to Treatment for Alcohol and Other Drug Use via Telehealth
儿科初级保健虚拟 SBIRT:通过远程医疗增加酒精和其他药物使用筛查、简短干预和转诊治疗的机会
  • 批准号:
    10706560
  • 财政年份:
    2022
  • 资助金额:
    $ 8.2万
  • 项目类别:
Virtual SBIRT for Pediatric Primary Care: Increasing Access to Screening, Brief Intervention and Referral to Treatment for Alcohol and Other Drug Use via Telehealth
儿科初级保健虚拟 SBIRT:通过远程医疗增加酒精和其他药物使用筛查、简短干预和转诊治疗的机会
  • 批准号:
    10606351
  • 财政年份:
    2022
  • 资助金额:
    $ 8.2万
  • 项目类别:
Addiction Telemedicine Consultation in Primary Care: Increasing Access to Pharmacotherapy and Specialty Treatment for Alcohol Problems
初级保健中的成瘾远程医疗咨询:增加酒精问题药物治疗和专业治疗的机会
  • 批准号:
    10212895
  • 财政年份:
    2020
  • 资助金额:
    $ 8.2万
  • 项目类别:
Addiction Telemedicine Consultation in Primary Care: Increasing Access to Pharmacotherapy and Specialty Treatment for Alcohol Problems
初级保健中的成瘾远程医疗咨询:增加酒精问题药物治疗和专业治疗的机会
  • 批准号:
    10616496
  • 财政年份:
    2020
  • 资助金额:
    $ 8.2万
  • 项目类别:
Addiction Telemedicine Consultation in Primary Care: Increasing Access to Pharmacotherapy and Specialty Treatment for Alcohol Problems
初级保健中的成瘾远程医疗咨询:增加酒精问题药物治疗和专业治疗的机会
  • 批准号:
    10397099
  • 财政年份:
    2020
  • 资助金额:
    $ 8.2万
  • 项目类别:
Implementation of Alcohol Screening and Brief Intervention in a Health System: Sustainability, Fidelity and Patient Outcomes
在卫生系统中实施酒精筛查和短暂干预:可持续性、忠诚度和患者结果
  • 批准号:
    10264654
  • 财政年份:
    2019
  • 资助金额:
    $ 8.2万
  • 项目类别:
Implementation of Alcohol Screening and Brief Intervention in a Health System: Sustainability, Fidelity and Patient Outcomes
在卫生系统中实施酒精筛查和短暂干预:可持续性、忠诚度和患者结果
  • 批准号:
    10413909
  • 财政年份:
    2019
  • 资助金额:
    $ 8.2万
  • 项目类别:
Implementation of Alcohol Screening and Brief Intervention in a Health System: Sustainability, Fidelity and Patient Outcomes
在卫生系统中实施酒精筛查和短暂干预:可持续性、忠诚度和患者结果
  • 批准号:
    10630316
  • 财政年份:
    2019
  • 资助金额:
    $ 8.2万
  • 项目类别:
Implementation of Alcohol Screening and Brief Intervention in a Health System: Sustainability, Fidelity and Patient Outcomes
在卫生系统中实施酒精筛查和短暂干预:可持续性、忠诚度和患者结果
  • 批准号:
    10172807
  • 财政年份:
    2019
  • 资助金额:
    $ 8.2万
  • 项目类别:
Population-based Screening and Brief Intervention in Primary Care: Health and Drinking Outcomes, Cost and Utilization
初级保健中基于人群的筛查和短期干预:健康和饮酒结果、成本和利用
  • 批准号:
    9355066
  • 财政年份:
    2017
  • 资助金额:
    $ 8.2万
  • 项目类别:

相似海外基金

WELL-CALF: optimising accuracy for commercial adoption
WELL-CALF:优化商业采用的准确性
  • 批准号:
    10093543
  • 财政年份:
    2024
  • 资助金额:
    $ 8.2万
  • 项目类别:
    Collaborative R&D
Investigating the Adoption, Actual Usage, and Outcomes of Enterprise Collaboration Systems in Remote Work Settings.
调查远程工作环境中企业协作系统的采用、实际使用和结果。
  • 批准号:
    24K16436
  • 财政年份:
    2024
  • 资助金额:
    $ 8.2万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Unraveling the Dynamics of International Accounting: Exploring the Impact of IFRS Adoption on Firms' Financial Reporting and Business Strategies
揭示国际会计的动态:探索采用 IFRS 对公司财务报告和业务战略的影响
  • 批准号:
    24K16488
  • 财政年份:
    2024
  • 资助金额:
    $ 8.2万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 8.2万
  • 项目类别:
    EU-Funded
Assessing the Coordination of Electric Vehicle Adoption on Urban Energy Transition: A Geospatial Machine Learning Framework
评估电动汽车采用对城市能源转型的协调:地理空间机器学习框架
  • 批准号:
    24K20973
  • 财政年份:
    2024
  • 资助金额:
    $ 8.2万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 8.2万
  • 项目类别:
    EU-Funded
Our focus for this project is accelerating the development and adoption of resource efficient solutions like fashion rental through technological advancement, addressing longer in use and reuse
我们该项目的重点是通过技术进步加快时装租赁等资源高效解决方案的开发和采用,解决更长的使用和重复使用问题
  • 批准号:
    10075502
  • 财政年份:
    2023
  • 资助金额:
    $ 8.2万
  • 项目类别:
    Grant for R&D
Engage2innovate – Enhancing security solution design, adoption and impact through effective engagement and social innovation (E2i)
Engage2innovate — 通过有效参与和社会创新增强安全解决方案的设计、采用和影响 (E2i)
  • 批准号:
    10089082
  • 财政年份:
    2023
  • 资助金额:
    $ 8.2万
  • 项目类别:
    EU-Funded
De-Adoption Beta-Blockers in patients with stable ischemic heart disease without REduced LV ejection fraction, ongoing Ischemia, or Arrhythmias: a randomized Trial with blinded Endpoints (ABbreviate)
在没有左心室射血分数降低、持续性缺血或心律失常的稳定型缺血性心脏病患者中停用β受体阻滞剂:一项盲法终点随机试验(ABbreviate)
  • 批准号:
    481560
  • 财政年份:
    2023
  • 资助金额:
    $ 8.2万
  • 项目类别:
    Operating Grants
Collaborative Research: SCIPE: CyberInfrastructure Professionals InnoVating and brOadening the adoption of advanced Technologies (CI PIVOT)
合作研究:SCIPE:网络基础设施专业人员创新和扩大先进技术的采用 (CI PIVOT)
  • 批准号:
    2321091
  • 财政年份:
    2023
  • 资助金额:
    $ 8.2万
  • 项目类别:
    Standard Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了